View Older Stories View More Recent Stories

Oct 26, 2020 08:30AM PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101 in Combination with Standard of Care Chemoradiotherapy in Advanced Cervical Cancer
Oct 1, 2020 08:30AM PDS Biotechnology Announces Participation in Noble Capital Markets Virtual Road Show Series
Aug 31, 2020 08:30AM PDS Biotechnology Announces Participation in Noble Capital Markets C-Suite Interview Series
Aug 13, 2020 06:00AM PDS Biotechnology Reports Financial Results for the Second Quarter 2020 and Provides Business Update
Jul 30, 2020 04:05PM PDS Biotechnology Announces Conference Call and Webcast for Second Quarter 2020 Financial Results
Jul 27, 2020 08:31AM PDS Biotechnology (PDSB) Announces Preclinical Data for PDS0203, T-Cell Activating Recombinant Protein Vaccine Against COVID-19
Jul 27, 2020 08:30AM PDS Biotech Announces Preclinical Data for PDS0203, a T-Cell Activating Recombinant Protein Vaccine Against COVID-19
Jul 14, 2020 08:33AM PDS Biotechnology (PDSB) Collaborator Granted NIAID Award to Accelerate Development of Versamune®-Based Universal Influenza Vaccine
Jul 14, 2020 08:30AM PDS Biotech Collaborator Granted NIAID Award to Accelerate Development of Versamune®-Based Universal Influenza Vaccine
Jun 22, 2020 08:30AM PDS Biotech Announces Publication of Preclinical Results of PDS0101 Combination by the National Cancer Institute in the Journal for ImmunoTherapy of Cancer
Jun 17, 2020 08:31AM PDS Biotechnology (PDSB), Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine
Jun 17, 2020 08:30AM PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine
Jun 15, 2020 08:32AM PDS Biotechnology (PDSB) Begins Phase 2 Trial of PDS0101 Led by the National Cancer Institute
Jun 15, 2020 08:30AM PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101 Led by the National Cancer Institute
Jun 4, 2020 04:05PM PDS Biotech Announces Clinical Trial of Its Lead Immunotherapy Product, PDS0101, in Combination with Chemoradiotherapy in Advanced Cervical Cancer
Jun 2, 2020 08:30AM PDS Biotechnology to Present at the 2020 Virtual Investor Summit
May 13, 2020 05:09PM PDS Biotechnology (PDSB) Announces Publication at American Society of Clinical Oncology ASCO
May 13, 2020 05:05PM PDS Biotechnology Announces Publication at American Society of Clinical Oncology (ASCO) 2020
May 13, 2020 06:00AM PDS Biotechnology Reports Financial Results for the First Quarter 2020 and Provides Business Update
May 4, 2020 08:30AM PDS Biotechnology Announces Conference Call and Webcast for First Quarter 2020 Financial Results
Apr 29, 2020 04:05PM PDS Biotechnology Expands CRADA with the National Cancer Institute to Include Second Versamune®-Based Anti-Cancer Product
Apr 16, 2020 08:30AM PDS Biotechnology Initiates Novel Vaccine Development Programs For COVID-19 and Universal Influenza; Delay of PDS0101 VERSATILE-002 trial
Apr 9, 2020 08:31AM PDS Biotechnology (PDSB) Adds Dr. Ilian Iliev to Board
Apr 9, 2020 08:30AM PDS Biotechnology Appoints Dr. Ilian Iliev to Board of Directors
Mar 27, 2020 04:15PM PDS Biotechnology Reports Full Year 2019 Financial Results and Provides Business Update
Mar 23, 2020 04:45PM PDS Biotechnology Announces Resignation of Andrew Saik as CFO
Mar 5, 2020 08:38AM PDS Biotechnology (PDSB) Expands Patent Portfolio for its Novel Versamune Platform
Mar 5, 2020 08:30AM PDS Biotechnology Expands Patent Portfolio for its Novel Versamune® Platform
Feb 27, 2020 08:30AM PDS Biotechnology Announces Commencement of Work Under a Pre-Clinical Collaboration with Farmacore Biotechnology for Tuberculosis
Feb 24, 2020 08:32AM PDS Biotechnology (PDSB) Names Kamil Ali-Jackson Esq. to Board
Feb 24, 2020 08:30AM PDS Biotechnology Appoints Kamil Ali-Jackson, Esq. to Board of Directors
Feb 17, 2020 08:30AM PDS Biotechnology to Present at Noble Capital Markets' 16th Annual Small & Microcap Investor Conference
Feb 14, 2020 04:05PM PDS Biotechnology Corporation Announces Closing of Public Offering
Feb 5, 2020 04:05PM PDS Biotechnology to Present at the 2020 BIO CEO & Investor Conference
Feb 5, 2020 04:05PM PDS Biotechnology to Present at the 2020 BIO CEO & Investor Conference
Dec 11, 2019 04:15PM PDS Biotechnology Announces Principal Investigator and Independent Data Monitoring Committee for its Phase 2 Clinical Collaboration with Merck
Dec 11, 2019 04:12PM PDS Biotechnology (PDSB) Reports Resignation of James Loughlin from Board
Dec 11, 2019 04:05PM PDS Biotechnology Announces Resignation of James Loughlin from Board of Directors
Dec 3, 2019 08:40AM PDS Biotechnology to Present at the 12th Annual LD Micro Main Event
Nov 25, 2019 08:30AM PDS Biotechnology to Present at the World Vaccine & Immunotherapy Congress West Coast 2019
View More Recent Stories View Older Stories